1.
Increased urinary albumin excretion is common in patients with essential hypertension and is at least to some extent correlated with prevailing blood pressure levels. However, the generalized vascular dysfunction present in advanced atherosclerotic disease may independently influence this parameter. 2. To evaluate this possibility, we assessed blood pressure, ultrasonographic carotid thickness, cardiac mass, minimum forearm vascular resistances, metabolic parameters and the angiotensinconverting enzyme genotype in patients with untreated essential hypertension and atherosclerotic peripheral vascular disease (n = 11). The results were compared with similar data obtained in matched groups of patients with uncomplicated hypertension and with normotensive control subjects (n = 11 per group).
3. Urinary albumin excretion was higher in hypertensive patients with atherosclerosis than in those without complications; carotid thickness was higher in atherosclerotic patients and a positive, statistically significant correlation existed between this parameter and urinary albumin excretion. In the same patient group, systolic blood pressure, fasting insulin and triacylglycerol levels were elevated and correlated with urinary albumin levels. However, differences in urinary albumin excretion persisted after taking into account the influence of those parameters by analysis of covariance. The distribution of angiotensin-converting enzyme genotype patterns and values of cardiac mass and minimum forearm vascular resistances did not differ significantly among the experimental groups. 4. The data suggest that vascular status may influence urinary albumin excretion in patients with essential hypertension, while confirming the importance of systolic blood pressure levels as a determinant of the raised urinary albumin excretion.
INTRODUCTION
Abnormal urinary albumin excretion (UAE) in a range not detectable by the usual dipstick methods for urine protein is frequently found in patients with essential hypertension [l] . This phenomenon is correlated, at least in part, with the level of blood pressure (BP) [l] , but generalized vascular dysfunction may contribute to it [2, 31. This hypothesis may apply also to the systemic microvascular damage associated with atherosclerotic disease [4] . Previous data have shown that microalbuminuria is predictive of mortality independently of hypertension in non-diabetic subjects [5] ; microalbuminuric subjects at risk of early atherosclerosis manifest evidence of diffuse vascular involvement such as increased levels of von Willebrand factor [6, 71 and reduced vascular response to local nitric oxide inhibition [8] ; finally, patients with advanced atherosclerotic disease show increments in UAE paralleled by abnormal neutrophilic activation [9] . Thus, both hypertension and atherosclerosis might independently contribute to albuminuria, but the overlap between the two conditions makes it difficult to understand their relative contribution to the changes in UAE. To explore this question, we compared patients with essential hypertension in whom atherosclerotic disease was fully expressed with patients without evidence of vascular pathology and with normal control subjects.
SUBJECTS AND METHODS

Subjects
Essential hypertensive patients with atherosclerotic peripheral vascular disease (PVD). Eleven essential hypertensive patients with angiographically documented aorto-iliac-femoral atherosclerotic PVD were included in the study [nine women, two men; age 58f8 years (SD), range 44-74]. They had fasting blood glucose levels less than 120 mgldl, serum creatinine less than 1.2 mgldl, total serum cholesterol of less than 300 mgldl, normal urinary sediment, no urinary tract infection, body mass index (BMI) less than 30 kg/m2 and no evidence or history of congestive heart failure, ischaemic heart disease, previous myocardial infarction, advanced chronic obstructive pulmonary disease, previous amputation, pain at rest or ischaemic trophic ulcers or gangrene. Haemodynamically significant carotid stenoses were also excluded by high-resolution ultrasonography. All had an ankle-brachial index [the ratio between systolic BP measured at the brachial and bilateral posterior tibia1 artery by Doppler sonography (Stereodop, Promelec, Bourgeais, Guer, France)] lower than 0.9 in at least one limb (0.55 f 0.1) and stable intermittent claudication (pain-free walking distance greater than 200 m on a treadmill). In all subjects, the angiograms had shown no evidence of renal artery stenosis, while routine clinical and haematological examinations excluded other secondary forms of hypertension. Renal ultrasound scans revealed normal-sized kidneys and no evidence of cortical scarring or obstructive uropathy in all patients. Two patients were active smokers; three were taking lipid-lowering drugs (gemfibrozil or simvastatin) and all received either ticlopidine or aspirin.
Uncomplicated essential hypertensive patients. Eleven sex-matched patients with uncomplicated essential hypertension (including two smokers) of similar age (56 f 9 years, range 43-73) underwent a similar diagnostic procedure (except angiography). PVD was excluded by verification of normal carotid, aortic and lower limb vessels as determined by echo Doppler scans and an ankle-brachial pressure index 2 1.
Normotensive control subjects. Eleven normal, nonobese, sedentary, sex-matched, untreated normotensive subjects (including two smokers) of similar age (57It9 years, range 46-70) with normal physical examination, routine blood and urinary tests, BP, ECG, abdominal echograms and ankle-brachial index were enrolled into the study as controls.
Hypertensive patients of both groups (four of whom had never been treated while calcium channel blockers or angiotensin-converting enzyme inhibitors or both were stopped for at least 2 weeks before the study) had BP values consistently greater than 140/90 mmHg as outpatients. Lipid-lowering drugs were withdrawn for the same period. At the end of the washout period, experimental evaluations were completed in a 2-week period. According to institutional guidelines, subjects were aware of the investigational nature of the study and agreed to participate. The study was carried out in accordance with the Declaration of Helsinki and the protocol was approved by the local ethics committee.
Experimental procedures
Casual systolic (SBP) and diastolic (DBP) (Korotkoff V phase) blood pressure were measured repeatedly in the morning in the supine position using a mercury sphygmomanometer. Anthropometric measurements (height and weight) were made after each participant had removed his or her shoes and upper garments. Blood samples were obtained between 08.00 and 09.00 hours after an overnight fast and 15 min of supine rest.
Urinary albumin excretion. To minimize the confounding influence of daily physical activity and to facilitate the collection procedure, urine was collected from 20.00 to 08.00 hours for 3 consecutive days as described in detail elsewhere [7] . Urinary albumin was measured by nephelometry (Istituto Behring, Scoppito, Italy; limit of detection 0.6 mgldl, interassay coefficient of variation 3.5%).
Carotid wall thickness. The sonographer demonstrated as clearly as possible the interfaces required for the measurements of the arterial wall thickness
[lo], searching for the thickest interface at 4-5 sites in the far wall of the right and left common carotid artery (i.e. the arterial segment extending from 8 to 16 mm below the tip of the flow divider into the common carotid artery) and the carotid bifurcation (bulb) using anterolateral, lateral and posterolateral fixed angles of examination. Patients who had tortuous or calcified arteries or without identifiable references were excluded. The ultrasound system was an AU 590 asynchronous system (Ansaldo, Genova, Italy) with a linear 7.5-MHz probe and an axial resolution of 0.1 mm. Scanning and measurements were obtained by the same observer unaware of the clinical status of the subject under examination. All measurements were made with the image at the maximum depth of focus. Gains and image pre-and post-processing options were set up by the operator for each patient and for each artery to obtain the best possible image. During scanning, distance measurements were recorded using software-driven cursors with a digital display expressing distances in mm. Complete scanning of each subject took about 20 min plus 20 min for the measurements. The intraindividual correlation of carotid scanning values at the common carotid and the bulb repeated at l-month intervals was 0.84 and 0.78 (P < 0.001) respectively.
Echocardiographic and plethysmographic parameters.
Wall thickness and chamber volumes were measured by mono-and bidimensional echocardiograms (Hewlett Packard Sonos 1000, Andover, MA, U.S.A.) with 2.5-and 3.5-MHz transducers [ll] . Forearm blood flow (FBF) was measured by strain gauge venous plethysmography (DE Hokanson EC 5R, Issaquah, WA, U.S.A.). For the evaluation of post-ischaemic reactive hyperaemia, maximal hyperaemia was induced by occlusion of the left forearm by inflation of a plethysmographic cuff to 300 mmHg for 13 min with dynamic exercise (10-20 hand contractions) during the last minute of ischaemia. Peak FBF was defined as the highest FBF during the 3 min after ischaemic release, and BP was measured indirectly at the contralateral forearm [ll] .
Metabolic parameters. Blood glucose was measured by the glucooxidase method. Immunoreactive insulin (IRI) concentrations were measured by radioimmunoassay (Sorin, Saluggia, Italy); total and high-density lipoprotein (HDL)-cholesterol and triacylglycerols were assessed by enzymic colorimetric techniques (Boehringer-Mannheim, Mannheim, Germany). Low-density lipoprotein (LDL)-cholesterol was calculated as total cholesterol -(HDL-cholesterol+ triacylglycerol/5).
Angiotensin-converting enzyme (ACE) D/I polymorphism. As ACE D/I gene polymorphism may influence UAE [12] and predict cardiovascular disease [13] , the parameter was determined in each subject from 1 p1 of EDTA-anticoagulated blood using a previously described procedure [13] . Assays were performed blindly with regard to study group or UAE status.
Data analysis
Data processing. UAE (pglmin) was determined as the average of three consecutive collections. The projection showing the greatest distance between the lumen-intima and the media-adventitia interface at the bulb level was defined as maximum intima-media thickness (IMTma); wall thickenings 21.6 mm were defined as plaques [14] . The average of the right and left far-wall intima-media determinations at the common carotid segment was defined as IMT. Reported values for casual systolic and diastolic BP were the average of multiple recordings. Minimal forearm vascular resistances (Rmin) were the ratio of preischaemic mean BP (MBP, diastolic + 1/3 pulse pressure) and maximum postischaemic peak flow. Left ventricular mass index (LVMI) was expressed in g/m2 to take into account body surface area. Forearm vascular resistances (FVR, MBPFBF) and BMI (body weighthquared surface area) were derived from standard formulae.
Statistics. Log transformation was applied to UAE, triacylglycerol and IRI as the raw data were not distributed normally. Descriptive statistics were arithmetic meansfSD or medians and ranges for skewed data. Differences among means were tested by one-way analysis of variance (ANOVA); in the presence of a significant F-value, between-group comparisons were performed by the ScheffSs method. Frequency distributions were analysed using x2 statistics. The intraindividual association of variables in hypertensive subjects was tested by Pearson's correlation coefficients. Analysis of covariance was used to take into account possible confounding influences on UAE of concomitant metric variables. Statistical significance was set at a P < 0.05. Calculations were performed using Statgraphics Plus (Manugistic, Release 1994, Rockville, MD, U.S.A.).
RESULTS
As a consequence of the selection procedure at entry, age, sex, smoking habits (see subjects and methods) and BMI (Table 1) were superimposable among the experimental groups.
UAE and cardiovascular parameters
SBP, DBP, LVMI, R m i n and FVR were higher in hypertensive patients than in control subjects ( Table  1) . UAE (Fig. l) , IMTma, IMT and SBP (Table 1, P<O.Ol for all) were higher in hypertensive patients with atherosclerosis than in hypertensive patients without complications. The other parameters did not differ significantly (Table 1) . IMTm, and UAE were correlated in the overall sample (r = 0.41, P<0.019, n = 33) and in the hypertensive subset (r = 0.45, Pc0.034, n = 22, Fig. 2) ; the correlation with IMT was only borderline (r = 0.39, P<O.11).
Plaques (IMTma2 1.6 mm) were present in 10 out of 11 atherosclerotic patients compared with two patients with uncomplicated hypertension and four control subjects (P<0.02). UAE in subjects with (n = 16) and without (n = 17) plaques was 17 (4-144) versus 13 (6-27) pg/min (P<0.05) respectively.
Metabolic parameters (Table 2)
Triacylglycerol (P < 0.01) and IRI levels (P < 0.03) were higher in essential hypertensive patients with PVD than in patients without complications and control subjects. The two variables were correlated (r = 0.67, P<O.OOl, n = 22) in hypertensive patients. Glucose and total, HDL-and LDL-cholesterol did not differ significantly among the study groups (Table 2) .
ACE genotype
UAE averaged 11 (4-144), 17 (6-87) and 10 (6-122) pg/min in subjects with the DD (n = 13, 39.4%), DI (n = 13, 39.4%) and II (n = 7, 21.2%) 
(73-155)
Glucose ( genotype respectively (not significant). Corresponding figures for IMTm, were 1.250.6, 1.9kO.9 and 1.4 50.6 mm respectively (not significant).
Other correlates of UAE in hypertensive patients
Significant univariate correlations existed between UAE and SBP (r = 0.76, P < 0.001), triacylglycerol (r = 0.75, P<O.OOl) and fasting circulating insulin (r = 0.43, P < 0.03) levels. Casual DBP, cardiac mass and minimum FVR showed no correlation.
Controlling for the influence of SBP, triacylglycerol and fasting insulin did not abolish the difference in UAE between patients with and without atherosclerosis ( Table 3) . DISCUSSION The increased albuminuria independent of casual SBP, triacylglycerol and fasting insulin levels as well as the positive correlation with carotid thickness suggests that widespread atherosclerosis exerted some independent influence on UAE in our hypertensive, atherosclerotic patients. The physiopathological link between peripheral macrovascular disease and UAE is unclear; altered glomerular permeability as a reflection of a systemic capillary damage [2, 31 concomitant with atherosclerosis [4] is ] than to hyperinsulinaemia or insulin sensitivity per se in patients with essential hypertension. In addition, microalbuminuria and hyperinsulinaemia independently predict future coronary heart disease, suggesting that independent mechanisms are operative [41] . Whether the results obtained in a general non-diabetic population apply to patients with essential hypertension remains to be elucidated.
In conclusion, our data suggest that, among several other factors, UAE levels may reflect the overall vascular status in patients with essential hypertension. Confirmation of this finding will await additional, larger studies.
